In the present study, as for SERPINB11, A2M is predominantly localized in endometrioid carcinoma, but there was little or no expression in serous, mucinous or clear cell carcinomas and normal ovaries (Figure 5A and-5B). This evidence concerns the gene A2M and endometrioid adenocarcinoma.